E.W. Scripps' debt restructuring offers temporary relief, but long-term issues remain. Find out why SSP stock is a Sell due ...
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...
Conversion of $450,000 of outstanding debt into shares strengthens the company's balance sheet and reduces overall debt burden. Lenders' decision to convert debt to equity at market price ...
This transaction strengthens the Company's balance sheet and reduces its debt burden ... in HCWC by converting a portion of their debt to equity at the current market price, without any discounts ...
(Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood’s balance sheet ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq ...